How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?

Health Research Policy and Systems

Volumn 14, Issue 1, 2016, Pages

  Teerawattananon, Yot ^a   Luz, Alia ^a   Pilasant, Songyot ^a   Tangsathitkulchai, Suteenoot ^a   Chootipongchaivat, Sarocha ^a   Tritasavit, Nattha ^a   Yamabhai, Inthira ^a   Tantivess, Sripen ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Chronic kidney disease; End stage renal disease; Low and middle income countries; Peritoneal dialysis; Renal replacement therapy; Universal health coverage

Indexed keywords

ASIA; CHRONIC KIDNEY FAILURE; COMMUNITY CARE; DATA PROCESSING; GOOD CLINICAL PRACTICE; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH INSURANCE; HEMODIALYSIS; HUMAN; PERITONEAL DIALYSIS; PILOT STUDY; PREVALENCE; PRIMARY PREVENTION; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; REVIEW; VALIDATION PROCESS; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ASIA; HEALTH CARE RATIONING; HEALTH SERVICES ACCESSIBILITY; HUMANS; QUALITY OF HEALTH CARE; QUALITY OF LIFE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UNIVERSAL HEALTH INSURANCE;

EID: 85007483091     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/s12961-016-0090-7     Document Type: Review

References (72)

1. O'Connell T, Rasanathan K, Chopra M. What does universal health coverage mean? Lancet. 2014;383(9913):277-9.
2. World Health Organization. Arguing for universal health coverage. Geneva: WHO; 2013.
3. World Health Organization. Health System Financing: The Path Towards Universal Health Coverage. Geneva: WHO; 2010.
4. Sustainable financing, universal health coverage and social insurance. World Health Assembly Resolution 58.33. 2005. http://www.who.int/health_financing/documents/cov-wharesolution5833/en/. Accessed 16 February 2015.
5. Damrongplasit K, Melnick G. Funding, coverage, and access under Thailand's Universal Health Insurance Program: An update after ten years. Appl Health Econ Health Policy. 2015;13(2):157-66.
6. Marshall SJ. Developing countries face double burden of diseases. Bull World Health Organ. 2004;82(7):556.
7. Borgonovi E, Compagni A. Sustaining universal health coverage: The interaction of social, political, and economic sustainability. Value Health. 2013;16:S34-8.
8. Alebiosu C, Ayodele O. The global burden of chronic kidney disease and the way forward. Ethn Dis. 2005;15:418-23.
9. USRDS: Special Analyses. http://www.usrds.org/2014/view/img_v2_10.html. Accessed 15 March 2016.
10. White S, Chadban S, Jan S, Chapmanc J, Cass A. How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ. 2008;86:229-37.
11. Couser W, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-70. doi:10.1038/ki.2011.368.
12. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975-82. doi:10.1016/S0140-6736(14)61601-9.
13. Davies S. Peritoneal dialysis-current status and future challenges. Nat Rev Nephrol. 2013;9:399-408.
14. Taslim BB. Identifying the barriers to achieving sustainable dialysis programs in sub-Saharan Africa: Nigeria as a reference point. J Nephrol Ther. 2014;4: 186 doi:10.4172/2161-0959.1000186.
15. Yu AW, Chau KF, Ho YW, Li PK. Development of the "peritoneal dialysis first" model in Hong Kong. Peritoneal Dialysis International. 2007 Jun 1; 27(Supplement 2):S53-5.
16. Yang W, Hwang S. Taiwan Society of Nephrology. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant. 2008;23(12):3977-82. doi:10.1093/ndt/gfn406.
17. Lim T, Goh A, Lim Y, Zaher Z, Suleiman B. How public and private reforms dramatically improved access to dialysis therapy in Malaysia. Health Aff. 2010;29(12):2214-22. doi:10.1377/hlthaff.2009.0135.
18. Joint Learning Network. Thailand: Universal Coverage Scheme. Joint Learning Network. http://programs.jointlearningnetwork.org/content/universal-coverage-scheme. Accessed 16 February 2015.
19. Rao A, Casula A, Castledine C. UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2013: National and Centre-specific Analyses. Nephron. 2015;129 Suppl 1:31-56.
20. Bresnahan M, Guan X, Smith S, Wang X, Edmundson J. Cultures of the soul: spiritual beliefs about organ donation in China and the United States. Chin J Commun. 2010;3(2):133-46.
21. Irving MJ, Tong A, Jan S, Cass A, Rose J, Chadban S, et al. Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature. Nephrol Dial Transplant. 2012;27(6):2526-33. doi:10. 1093/ndt/gfr683.
22. Hebert P, Rivera J, Eng K, Lee R, Seto-Yee S. Improving organ donation in Chinese community in New York. In: Siegel JT, Alvaro EM, editors. Understanding organ donation: applied behavioral science perspectives. Chichester and Malden, MA: Wiley-Blackwell; 2010. p. xxii. 368.
23. Noppakun K, Ingsathit A, Pongskul C, Premasthian N, Avihingsanon Y, Lumpaopong A, et al. A 25-year experience of kidney transplantation in Thailand: Report from the Thai Transplant Registry. Nephrology. 2015;20(3):177-83.
24. Kanchanachitra C, Lindelow M, Johnston T, Hanvoravongchai P, Lorenzo FM, Huong NL, et al. Human resources for health in southeast Asia: shortages, distributional challenges, and international trade in health services. Lancet. 2011;377(9767):769-81.
25. Jensen CE, S�rensen P, Petersen KD. In Denmark kidney transplantation is more cost-effective than dialysis. Dan Med J. 2014;61(3):A4796.
26. Haller M, Gutjahr G, Kramar R, Harnoncourt F, Oberbauer R. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant. 2011; 26(9):2988-95.
27. Jarl J, Gerdtham U-G. Economic evaluations of organ transplantations-a systematic literature review. Nordic J Health Econ. 2011;1(1):Jarl.
28. Rocha MJ, Ferreira S, Martins LS, Almeida M, Dias L, Pedroso S, et al. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis. Clin Transpl. 2012;26(4):529-31.
29. Klarenbach S, Manns B. Economic evaluation of dialysis therapies. Seminars in Nephrology. Philadelphia, PA: Elsevier; 2009.
30. Li P. Global burden of end-stage renal disease, solutions and future development. International Forum on Peritoneal Dialysis as a Priority Health Policy in Asia. Bangkok, November 27, 2014.
31. Leong G, Ngo L, Meng O, et al. National 21st report of the Malaysian Renal Dialysis Registry. 2013. http://203.115.198.108/Doc/PublicDoc_PB/Publication/mdtr2013/FULL_REPORT_2013.pdf. Accessed 17 February 2015.
32. Li P, Chow K. The cost barrier to peritoneal dialysis in the developing world-an Asian perspective. Perit Dial Int. 2001;21 Suppl 3:S307-13.
33. Registry TUR. UK Renal Registry 16th Annual Report. 2013. https://www. renalreg.org/reports/2013-the-sixteenth-annual-report/. Accessed 16 February 2015.
34. USRDS. Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2014.
35. Ho Y, Ka-Foon C, Choy B, et al. Hong Kong Renal Registry Report 2012. Hong Kong J Nephrol. 2013;15(1):28-43.
36. Praditpornsilpa K. Thailand Renal Replacement Therapy Registry Report. 2011 http://www.nephrothai.org/trt/trt.asp?type=TRT&news_id=391. Accessed 22 January 2015.
37. Yu A, Chau K, Ho Y, Li P. Development of the "Peritoneal Dialysis First" Model in Hong Kong. Perit Dial Int. 2007;27(Supplement 2):S53-5.
38. Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for endstage renal disease: evidence for coverage decisions in Thailand. Value Health. 2007;10(1):61-72.
39. Suja A, Anju R, Anju V, Neethu J, Peeyush P, Saraswathy R. Economic evaluation of end stage renal disease patients undergoing hemodialysis. J Pharm Bioallied Sci. 2012;4(2):107-11. doi:10.4103/0975-7406.94810.
40. Chuengsaman P. Psychosocial innovation for improved quality of life. International Forum on Peritoneal Dialysis as a Priority Health Policy in Asia; 27-28 November 2014; Courtyard Marriot Hotel. Bangkok. 2014.
41. Sinnakirouchenan R, Holley J. Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues. Adv Chronic Kidney Dis. 2011;18(6):428-32.
42. Prodjosudjadi W, Suhardjono A. End-stage renal disease in Indonesia: treatment development. Ethn Dis. 2009;19(1 Suppl 1):S1-33-6.
43. Philhealth coverage for hemodialysis. July 6, 2015. http://www. healthphilippines.net/2014/08/philhealth-coverage-for-hemodialysis/. Accessed 22 January 2016.
44. Pa VJN. Hemodialysis in Asia. Kidney Dis. 2015;1:165-77. doi:10.1159/000441816.
45. Brown E. Peritoneal dialysis versus hemodialysis in the elderly. Perit Dial Int. 1999;19(4):311.
46. H�rl WH, de Alvaro F, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant. 1999;14 Suppl 6:10-5. doi:10.1093/ndt/14.suppl_6.10.
47. Goodlad C, Brown E. The role of peritoneal dialysis in modern renal replacement therapy. Postgrad Med J. 2013;89(1056):584-90. doi:10.1136/postgradmedj-2012-131406.
48. Li P, Chow K. Peritoneal dialysis-first policy made successful: perspectives and actions. Am J Kidney Dis. 2013;62:993-1005.
49. Chaudhary K, Harbaksh S, Ramesh K. Peritoneal dialysis first: rationale. Clin J Am Soc Nephrol. 2011;6(2):447-56.
50. Calman KC. The ethics of allocation of scarce health care resources: a view from the centre. J Med Ethics. 1994;20(2):71-4.
51. Dukpa W, Teerawattananon Y, Rattanavipapong W, Srinonprasert V, Tongsri W, Kingkaew P, et al. Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan. Health Policy Plan. 2014;30(8):1032-43.
52. Chootipongchaivat S, Luz A, Pilasant S, Tangsathitkulchai S, Tantivess S, Teerawattananon Y, et al. Technical Report: International Forum on Peritoneal Dialysis as a Priority Health Policy in Asia. Bangkok: Health Intervention and Technology Assessment Program (HITAP); 2014.
53. National Institute for Health and Care Excellence. Chronic kidney disease NICE quality standard 5. 2005. https://www.nice.org.uk/guidance/qs5. Accessed 2 February, 2015.
54. Bailey J. ACE inhibitors vs. ARBs for patients with diabetic kidney disease. Am Fam Physician. 2007;76(1):68-9.
55. Sittipreechachan P. Sharing experience of palliative care. J Nurs Sci. 2013; 30(3)18-26.
56. The World Bank. Population, total. http://data.worldbank.org/indicator/SP. POP.TOTL. Accessed 16 February 2015.
57. The World Bank. GDP per capita (current US$). http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 16 February 2015.
58. The World Bank. Health expenditure, total (% of GDP). http://data. worldbank.org/indicator/SH.XPD.TOTL.ZS. Accessed 16 February 2015.
59. International Diabetes Federation. IDF diabetes atlas sixth edition. 2014. http://www.diabetesatlas.org/across-the-globe.html. Accessed 3 February 2015.
60. Bennett CL, Pei GK, Ultmann JE. Western impressions of the Hong Kong health care system. West J Med. 1996;165(1-2):37-42.
61. WHO and Department of Health, Hong Kong. Health Service Delivery Profile: Hong Kong (China). 2012. http://www.wpro.who.int/health_ services/service:delivery_profile_hong_kong_(china).pdf. Accessed 3 February 2015.
62. Food and Health Bureau. Health Expenditure: total expenditure on health (TEH) as % of GDP. In: Health Statistics. http://www.fhb.gov.hk/statistics/en/statistics/health_expenditure.htm. Accessed 17 February 2015.
63. Simmonds A, Hort K. Institutional analysis of Indonesia's proposed road map to universal health coverage. Melbourne: Nossal Institute for Global Health, University of Melbourne; 2013. Contract No.: 33.
64. Widowati K. Indonesia aims for universal health coverage by 2019 International Health Policies. http://archief.internationalhealthpolicies.org/archives/indonesia-aims-universal-health-coverage-2019/. Accessed 14 March 2016.
65. Savedoff W, Smith A. Achieving universal health coverage: learning from Chile, Japan, Malaysia and Sweden. Maine: Results for Development Institute (R4D); 2011.
66. 2011-2016 National Objectives for Health, Health Sector Reform Agenda Monographs. DOH HSRA Monograph No. 12. Manila: Department of Health. 2016 www.doh.gov.ph/sites/default/files/publications/noh2016.pdf.
67. Paterno R. The Future of Universal Health Coverage: A Philippine Perspective. Global Health Government. 2013. http://blogs.shu.edu/ghg/2013/09/18/thefuture-of-universal-health-coverage-a-philippine-perspective/. Accessed 3 February 2015.
68. Kreng V, Yang C. The equality of resource allocation in health care under the National Health Insurance System in Taiwan. Health Policy. 2011;100(2-3):203-10. doi:10.1016/j.healthpol.2010.08.003.
69. International Monetary Fund. http://www.imf.org/external/pubs/ft/weo/2014/02/weodata/download.aspx. Accessed 14 March 2016.
70. Ministry of Health and Welfare, Taiwan. National Health Expenditure. 2013. http://www.imf.org/external/pubs/ft/weo/2014/02/weodata/download.aspx. Accessed 3 February 2015.
71. Tangcharoensathien V, Limwattananon S, Patcharanarumol W, Thammatacharee J. Monitoring and evaluating progress towards Universal Health Coverage in Thailand. PLoS Med. 2014;11(9):e1001726. doi:10.1371/journal.pmed.1001726.
72. Majeed A. Universal health coverage in the United Kingdom. J Ambul Care Manage. 2003;26(4):373-7.